|
|
|
|
|
|
by et2o
1965 days ago
|
|
|
“nobody has made a compelling argument for WGA for personalized med” is a huge overreach. It’s done routinely now at most academic cancer centers and often is useful for guiding treatment decisions. There are several multi billion dollar companies that do this already. |
|
|